Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Total Liabilities (2019 - 2025)

Historic Total Liabilities for BioScience Health Innovations (BHIC) over the last 7 years, with Q3 2025 value amounting to $356140.0.

  • BioScience Health Innovations' Total Liabilities rose 68191.76% to $356140.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $356140.0, marking a year-over-year increase of 68191.76%. This contributed to the annual value of $38548.0 for FY2024, which is 6150.9% down from last year.
  • Per BioScience Health Innovations' latest filing, its Total Liabilities stood at $356140.0 for Q3 2025, which was up 68191.76% from $337632.0 recorded in Q2 2025.
  • Over the past 5 years, BioScience Health Innovations' Total Liabilities peaked at $356140.0 during Q3 2025, and registered a low of $1860.0 during Q3 2022.
  • For the 5-year period, BioScience Health Innovations' Total Liabilities averaged around $78489.5, with its median value being $38548.0 (2024).
  • Its Total Liabilities has fluctuated over the past 5 years, first plummeted by 9026.48% in 2022, then skyrocketed by 127758.37% in 2025.
  • Quarter analysis of 5 years shows BioScience Health Innovations' Total Liabilities stood at $23015.0 in 2021, then plummeted by 87.54% to $2867.0 in 2022, then soared by 3393.13% to $100148.0 in 2023, then crashed by 61.51% to $38548.0 in 2024, then surged by 823.89% to $356140.0 in 2025.
  • Its Total Liabilities stands at $356140.0 for Q3 2025, versus $337632.0 for Q2 2025 and $132921.0 for Q1 2025.